|
This drug Sutent was studied in metastatic breast cancer in women who had lots of prior chemo. Data was presented last MAY at ASCO that showed benefit.
The company is waiting for approval in renal and gastric cancer probably next year and in the meantime has a compassionate use program in place for these types of cancer. Yet they continue to refuse the same program for women with breast cancer and won't say why. It seems discriminatory to me.....
|